Shen D - Search Results

1

ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast.

Ping Z, Siegal GP, Harada S, Eltoum IE, Youssef M, Shen T, He J, Huang Y, Chen D, Li Y, Bland KI, Chang HR, Shen D. Ping Z, et al. Among authors: shen t, shen d. Oncotarget. 2016 Dec 6;7(49):80655-80663. doi: 10.18632/oncotarget.13019. Oncotarget. 2016. PMID: 27811364 Free PMC article.

2

A microscopic landscape of the invasive breast cancer genome.

Ping Z, Xia Y, Shen T, Parekh V, Siegal GP, Eltoum IE, He J, Chen D, Deng M, Xi R, Shen D. Ping Z, et al. Among authors: shen t, shen d. Sci Rep. 2016 Jun 10;6:27545. doi: 10.1038/srep27545. Sci Rep. 2016. PMID: 27283966 Free PMC article.

3

In silico identification of breast cancer genes by combined multiple high throughput analyses.

Shen D, He J, Chang HR. Shen D, et al. Int J Mol Med. 2005 Feb;15(2):205-12. Int J Mol Med. 2005. PMID: 15647832

4

Mining genome sequencing data to identify the genomic features linked to breast cancer histopathology.

Ping Z, Siegal GP, Almeida JS, Schnitt SJ, Shen D. Ping Z, et al. Among authors: shen d. J Pathol Inform. 2014 Jan 31;5(1):3. doi: 10.4103/2153-3539.126147. eCollection 2014. J Pathol Inform. 2014. PMID: 24672738 Free PMC article.

5

The Utility of Phosphohistone H3 in Breast Cancer Grading.

Cui X, Harada S, Shen D, Siegal GP, Wei S. Cui X, et al. Among authors: shen d. Appl Immunohistochem Mol Morphol. 2015 Nov-Dec;23(10):689-95. doi: 10.1097/PAI.0000000000000137. Appl Immunohistochem Mol Morphol. 2015. PMID: 25611243 Clinical Trial.

6

Loss of annexin A1 expression in human breast cancer detected by multiple high-throughput analyses.

Shen D, Chang HR, Chen Z, He J, Lonsberry V, Elshimali Y, Chia D, Seligson D, Goodglick L, Nelson SF, Gornbein JA. Shen D, et al. Biochem Biophys Res Commun. 2005 Jan 7;326(1):218-27. doi: 10.1016/j.bbrc.2004.10.214. Biochem Biophys Res Commun. 2005. PMID: 15567174 Clinical Trial.

7

Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis.

Shen D, Nooraie F, Elshimali Y, Lonsberry V, He J, Bose S, Chia D, Seligson D, Chang HR, Goodglick L. Shen D, et al. Hum Pathol. 2006 Dec;37(12):1583-91. doi: 10.1016/j.humpath.2006.06.001. Epub 2006 Aug 10. Hum Pathol. 2006. PMID: 16949910

8

Tumor proteomic profiling predicts the susceptibility of breast cancer to chemotherapy.

He J, Shen D, Chung DU, Saxton RE, Whitelegge JP, Faull KF, Chang HR. He J, et al. Among authors: shen d. Int J Oncol. 2009 Oct;35(4):683-92. doi: 10.3892/ijo_00000380. Int J Oncol. 2009. PMID: 19724903 Clinical Trial.

9

Induction of MUC1-specific cellular immunity by a recombinant BCG expressing human MUC1 and secreting IL2.

He J, Shen D, O'Donnell MA, Chang HR. He J, et al. Among authors: shen d. Int J Oncol. 2002 Jun;20(6):1305-11. Int J Oncol. 2002. PMID: 12012014

10

Higher levels of GATA3 predict better survival in women with breast cancer.

Yoon NK, Maresh EL, Shen D, Elshimali Y, Apple S, Horvath S, Mah V, Bose S, Chia D, Chang HR, Goodglick L. Yoon NK, et al. Among authors: shen d. Hum Pathol. 2010 Dec;41(12):1794-801. doi: 10.1016/j.humpath.2010.06.010. Hum Pathol. 2010. PMID: 21078439 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,435 results

Search Page

Filters